Novel Pharmacotherapy for Hypertrophic Cardiomyopathy
Publication/Presentation Date
1-2019
Abstract
Medical therapy for hypertrophic cardiomyopathy (HCM) has focused on minimizing the impact of symptoms due to left ventricular outflow tract obstruction and diastolic dysfunction. This article briefly discusses currently available therapy and focuses on both clinically available medications with novel applications for HCM as well as novel medications under development with specific indication for HCM. Finally, a brief summary of the current gaps and potential targets for pharmacotherapy is discussed.
Volume
37
Issue
1
First Page
113
Last Page
117
Published In/Presented At
Wong, T. C., Martinez, M. w. (2018). Novel Pharmacotherapy for Hypertrophic Cardiomyopathy. Cardiology Clinics, 37(1), 113-117. DOI: /doi.org/10.1016/j.ccl.2018.08.008
Disciplines
Cardiology
PubMedID
30447712
Department(s)
Department of Medicine, Cardiology Division, Department of Medicine Faculty
Document Type
Article